vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Information Services Group Inc. (III). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $61.2M, roughly 1.4× Information Services Group Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 4.3%, a 18.5% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 5.9%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $4.3M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -2.4%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...
FDMT vs III — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $61.2M |
| Net Profit | $19.4M | $2.6M |
| Gross Margin | — | 44.8% |
| Operating Margin | 17.3% | 8.4% |
| Net Margin | 22.8% | 4.3% |
| Revenue YoY | 8508900.0% | 5.9% |
| Net Profit YoY | 139.1% | -14.1% |
| EPS (diluted) | $0.43 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $61.2M | ||
| Q3 25 | $90.0K | $62.4M | ||
| Q2 25 | $15.0K | $61.6M | ||
| Q1 25 | $14.0K | $59.6M | ||
| Q4 24 | $1.0K | $57.8M | ||
| Q3 24 | $3.0K | $61.3M | ||
| Q2 24 | $5.0K | $64.3M | ||
| Q1 24 | $28.0K | $64.3M |
| Q4 25 | $19.4M | $2.6M | ||
| Q3 25 | $-56.9M | $3.1M | ||
| Q2 25 | $-54.7M | $2.2M | ||
| Q1 25 | $-48.0M | $1.5M | ||
| Q4 24 | — | $3.0M | ||
| Q3 24 | $-43.8M | $1.1M | ||
| Q2 24 | $-35.0M | $2.0M | ||
| Q1 24 | $-32.4M | $-3.4M |
| Q4 25 | — | 44.8% | ||
| Q3 25 | — | 42.2% | ||
| Q2 25 | — | 42.2% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | — | 41.5% | ||
| Q3 24 | — | 40.4% | ||
| Q2 24 | — | 39.5% | ||
| Q1 24 | — | 36.1% |
| Q4 25 | 17.3% | 8.4% | ||
| Q3 25 | -67983.3% | 7.4% | ||
| Q2 25 | -396373.3% | 7.6% | ||
| Q1 25 | -383007.1% | 5.7% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | -1704400.0% | 7.0% | ||
| Q2 24 | -849120.0% | 5.7% | ||
| Q1 24 | -136200.0% | -3.7% |
| Q4 25 | 22.8% | 4.3% | ||
| Q3 25 | -63195.6% | 4.9% | ||
| Q2 25 | -364386.7% | 3.5% | ||
| Q1 25 | -342657.1% | 2.5% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | -1461433.3% | 1.9% | ||
| Q2 24 | -699060.0% | 3.2% | ||
| Q1 24 | -115717.9% | -5.3% |
| Q4 25 | $0.43 | $0.06 | ||
| Q3 25 | $-1.01 | $0.06 | ||
| Q2 25 | $-0.98 | $0.04 | ||
| Q1 25 | $-0.86 | $0.03 | ||
| Q4 24 | — | $0.07 | ||
| Q3 24 | $-0.79 | $0.02 | ||
| Q2 24 | $-0.63 | $0.04 | ||
| Q1 24 | $-0.66 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $28.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $94.7M |
| Total Assets | $566.7M | $211.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $28.7M | ||
| Q3 25 | $305.1M | $28.7M | ||
| Q2 25 | $293.2M | $25.2M | ||
| Q1 25 | $321.4M | $20.1M | ||
| Q4 24 | $424.9M | $23.1M | ||
| Q3 24 | $501.9M | $9.7M | ||
| Q2 24 | $541.9M | $11.8M | ||
| Q1 24 | $525.9M | $14.0M |
| Q4 25 | $505.7M | $94.7M | ||
| Q3 25 | $369.0M | $94.7M | ||
| Q2 25 | $420.9M | $94.1M | ||
| Q1 25 | $469.7M | $95.0M | ||
| Q4 24 | $510.6M | $96.3M | ||
| Q3 24 | $552.9M | $96.6M | ||
| Q2 24 | $588.3M | $95.5M | ||
| Q1 24 | $600.6M | $95.6M |
| Q4 25 | $566.7M | $211.0M | ||
| Q3 25 | $424.0M | $213.3M | ||
| Q2 25 | $473.6M | $200.7M | ||
| Q1 25 | $515.7M | $202.4M | ||
| Q4 24 | $560.4M | $204.5M | ||
| Q3 24 | $604.0M | $227.1M | ||
| Q2 24 | $620.1M | $235.3M | ||
| Q1 24 | $629.9M | $234.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $5.1M |
| Free Cash FlowOCF − Capex | $28.5M | $4.3M |
| FCF MarginFCF / Revenue | 33.5% | 7.0% |
| Capex IntensityCapex / Revenue | 0.1% | 1.2% |
| Cash ConversionOCF / Net Profit | 1.47× | 1.94× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $25.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $5.1M | ||
| Q3 25 | $-46.5M | $11.1M | ||
| Q2 25 | $-43.4M | $11.9M | ||
| Q1 25 | $-47.8M | $978.0K | ||
| Q4 24 | $-134.6M | $6.6M | ||
| Q3 24 | $-29.4M | $8.8M | ||
| Q2 24 | $-30.2M | $2.2M | ||
| Q1 24 | $-29.1M | $2.3M |
| Q4 25 | $28.5M | $4.3M | ||
| Q3 25 | $-46.6M | $9.5M | ||
| Q2 25 | $-43.4M | $11.1M | ||
| Q1 25 | $-48.4M | $141.0K | ||
| Q4 24 | $-138.4M | $6.0M | ||
| Q3 24 | $-31.2M | $8.4M | ||
| Q2 24 | $-30.6M | $1.3M | ||
| Q1 24 | $-29.8M | $1.3M |
| Q4 25 | 33.5% | 7.0% | ||
| Q3 25 | -51765.6% | 15.2% | ||
| Q2 25 | -289620.0% | 18.0% | ||
| Q1 25 | -345635.7% | 0.2% | ||
| Q4 24 | -13837100.0% | 10.4% | ||
| Q3 24 | -1038966.7% | 13.7% | ||
| Q2 24 | -611840.0% | 2.0% | ||
| Q1 24 | -106421.4% | 2.0% |
| Q4 25 | 0.1% | 1.2% | ||
| Q3 25 | 101.1% | 2.5% | ||
| Q2 25 | 440.0% | 1.4% | ||
| Q1 25 | 4507.1% | 1.4% | ||
| Q4 24 | 378600.0% | 0.9% | ||
| Q3 24 | 59266.7% | 0.6% | ||
| Q2 24 | 6980.0% | 1.4% | ||
| Q1 24 | 2535.7% | 1.6% |
| Q4 25 | 1.47× | 1.94× | ||
| Q3 25 | — | 3.62× | ||
| Q2 25 | — | 5.46× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 2.15× | ||
| Q3 24 | — | 7.66× | ||
| Q2 24 | — | 1.07× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
